Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer

NCT00051688 is registered in ClinicalTrials.gov with Chiron Corporation as lead sponsor.

NCT NCT00051688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00051688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Lead sponsor
Chiron Corporation
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2003
Completion date
August 31, 2004
Enrollment
Not reported
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms